Bone Marrow Derived Stem Cells Mobilization for treatment of Asherman's syndrome, Atrophic endometrium, and Recurrent implantation failure

Women with Asherman’s syndrome (AS), atrophic/thin endometrium (AE) or recurrent implantation failure (RIF). This trial is researching if women given the bone marrow stem cell stimulating drug can replenish stem cells in the endometrium to repair and thicken their endometrium and achieve a viable pregnancy. Participant’s own bone marrow stem cells are an effective medical therapy for the treatment of AS, AE or RIF syndrome.